BANGKOK (NNT) – The National Research Council of Thailand and National Vaccine Institute have revealed that more than 20 COVID-19 vaccines are being researched and developed in Thailand, while three candidates are undergoing human trials.
ChulaCov19, an mRNA vaccine developed by Chulalongkorn University, is in the first phase of human trials on 72 volunteers. Two doses of the vaccine were given at an interval of 21 days.
Full story: National News Bureau of Thailand
Reporter: Subhabhong Rarueysong,
Rewriter: Hugh Brammar
National News Bureau of Thailand